Literature DB >> 23427157

Formation of covalently modified folding intermediates of simian virus 40 Vp1 in large T antigen-expressing cells.

Marika Watanabe1, Ellen Phamduong, Chu-Han Huang, Noriko Itoh, Janie Bernal, Akira Nakanishi, Kathleen Rundell, Ole Gjoerup, Harumi Kasamatsu.   

Abstract

The folding and pentamer assembly of the simian virus 40 (SV40) major capsid protein Vp1, which take place in the infected cytoplasm, have been shown to progress through disulfide-bonded Vp1 folding intermediates. In this report, we further demonstrate the existence of another category of Vp1 folding or assembly intermediates: the nonreducible, covalently modified mdVp1s. These species were present in COS-7 cells that expressed a recombinant SV40 Vp1, Vp1ΔC, through plasmid transfection. The mdVp1s persisted under cell and lysate treatment and SDS-PAGE conditions that are expected to have suppressed the formation of artifactual disulfide cross-links. As shown through a pulse-chase analysis, the mdVp1s were derived from the newly synthesized Vp1ΔC in the same time frame as Vp1's folding and oligomerization. The apparent covalent modifications occurred in the cytoplasm within the core region of Vp1 and depended on the coexpression of the SV40 large T antigen (LT) in the cells. Analogous covalently modified species were found with the expression of recombinant polyomavirus Vp1s and human papillomavirus L1s in COS-7 cells. Furthermore, the mdVp1s formed multiprotein complexes with LT, Hsp70, and Hsp40, and a fraction of the largest mdVp1, md4, was disulfide linked to the unmodified Vp1ΔC. Both mdVp1 formation and most of the multiprotein complex formation were blocked by a Vp1 folding mutation, C87A-C254A. Our observations are consistent with a role for LT in facilitating the folding process of SV40 Vp1 by stimulating certain covalent modifications of Vp1 or by recruiting certain cellular proteins.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23427157      PMCID: PMC3624288          DOI: 10.1128/JVI.00955-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Identification of amino acid residues within simian virus 40 capsid proteins Vp1, Vp2, and Vp3 that are required for their interaction and for viral infection.

Authors:  Akira Nakanishi; Akiko Nakamura; Robert Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

Review 2.  Chaperone-assisted folding of newly synthesized proteins in the cytosol.

Authors:  Elke Deuerling; Bernd Bukau
Journal:  Crit Rev Biochem Mol Biol       Date:  2004 Sep-Dec       Impact factor: 8.250

3.  Association of simian virus 40 vp1 with 70-kilodalton heat shock proteins and viral tumor antigens.

Authors:  Peggy P Li; Noriko Itoh; Marika Watanabe; Yunfan Shi; Peony Liu; Hui-Jung Yang; Harumi Kasamatsu
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

4.  Pairs of Vp1 cysteine residues essential for simian virus 40 infection.

Authors:  Peggy P Li; Akira Nakanishi; Vanessa Fontanes; Harumi Kasamatsu
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

5.  Generation of HPV pseudovirions using transfection and their use in neutralization assays.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  Methods Mol Med       Date:  2005

6.  Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome.

Authors:  Akira Nakanishi; Noriko Itoh; Peggy P Li; Hiroshi Handa; Robert C Liddington; Harumi Kasamatsu
Journal:  J Virol       Date:  2007-01-31       Impact factor: 5.103

7.  Induction of interferon-stimulated genes by Simian virus 40 T antigens.

Authors:  Abhilasha V Rathi; Paul G Cantalupo; Saumendra N Sarkar; James M Pipas
Journal:  Virology       Date:  2010-08-07       Impact factor: 3.616

8.  Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays.

Authors:  Yanis L Tolstov; Diana V Pastrana; Huichen Feng; Jürgen C Becker; Frank J Jenkins; Stergios Moschos; Yuan Chang; Christopher B Buck; Patrick S Moore
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

9.  Arrangement of L2 within the papillomavirus capsid.

Authors:  Christopher B Buck; Naiqian Cheng; Cynthia D Thompson; Douglas R Lowy; Alasdair C Steven; John T Schiller; Benes L Trus
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

10.  Early events during BK virus entry and disassembly.

Authors:  Mengxi Jiang; Johanna R Abend; Billy Tsai; Michael J Imperiale
Journal:  J Virol       Date:  2008-11-26       Impact factor: 5.103

View more
  1 in total

1.  Inhibition of large T antigen ATPase activity as a potential strategy to develop anti-polyomavirus JC drugs.

Authors:  Parmjeet Randhawa; G Zeng; M Bueno; A Salgarkar; Andrew Lesniak; K Isse; K Seyb; A Perry; I Charles; C Hustus; M Huang; M Smith; Marcie A Glicksman
Journal:  Antiviral Res       Date:  2014-10-15       Impact factor: 5.970

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.